title: Serum proteins modulate lipopolysaccharide and lipoteichoic acid-induced activation and contribute to the clinical outcome of sepsis.
abstract: Bacterial cell wall components, such LPS and LTA, are potent initiators of an inflammatory response that can lead to septic shock. The advances in the past were centered around membrane-bound receptors and intracellular events, but our understanding of the initial interactions of these bacterial components with serum proteins as they enter the bloodstream remain unclear. In this study we identified several serum proteins, which are involved in the innate recognition of bacterial products. Using affinity chromatography and mass spectrometry we performed proteomic analysis of LPS- and LTA-binding serum proteins. We isolated proteins from normal serum that can interact with LPS and LTA. Fluorescent binding experiments and cytokine assays revealed that serum proteins, such as apolipoprotein, LDL, transferrin and holotransferrin could neutralize LPS/LTA binding as well as the subsequent inflammatory response, suggesting that serum proteins modulate LPS/LTA-induced responses. When compared with the proteomic profile of serum from septic patients it was shown that these proteins were in lower abundance. Investigation of serum proteins in 25 critically ill patients with a mortality rate of 40% showed statistically higher levels of these proteins in survivors. Patients surviving sepsis had statistically significant higher levels of apolipoprotein, albumin, LDL, transferrin and holotransferrin than individuals that succumbed, suggesting that these proteins have an inhibitory effect on LPS/LTA-induced inflammatory responses and in their absence there might be an augmented inflammatory response in sepsis.
authors.affiliation: Cardiff University School of Medicine, Department of Child Health, University Hospital of Wales, Cardiff, UK.
authors.forename: Martha
authors.initials: M
authors.lastname: Triantafilou
authors.forename: Marios-Angelos
authors.initials: MA
authors.lastname: Mouratis
authors.forename: Philipp M
authors.initials: PM
authors.lastname: Lepper
authors.forename: Rowenna Mitch
authors.initials: RM
authors.lastname: Haston
authors.forename: Fiona
authors.initials: F
authors.lastname: Baldwin
authors.forename: Sarah
authors.initials: S
authors.lastname: Lowes
authors.forename: Mohamed Abd Elrahman
authors.initials: MA
authors.lastname: Ahmed
authors.forename: Christian
authors.initials: C
authors.lastname: Schumann
authors.forename: Owen
authors.initials: O
authors.lastname: Boyd
authors.forename: Kathy
authors.initials: K
authors.lastname: Triantafilou
mesh_terms: D000328:Adult; D000368:Aged; D001798:Blood Proteins / Q000737:chemistry / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D002846:Chromatography, Affinity; D016638:Critical Illness; D016207:Cytokines / Q000378:metabolism; D005260:Female; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology* / Q000378:metabolism*; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D011485:Protein Binding; D020543:Proteome / Q000032:analysis; D018805:Sepsis / Q000276:immunology* / Q000473:pathology*; D016019:Survival Analysis; D013682:Teichoic Acids / Q000276:immunology* / Q000378:metabolism*; D055815:Young Adult
chemical_list: D001798:Blood Proteins; D016207:Cytokines; D008070:Lipopolysaccharides; D020543:Proteome; D013682:Teichoic Acids; C009900:lipoteichoic acid